Educational training to help older patients manage Type 2 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The JACARDI trial is a multicenter initiative aimed at enhancing the eHealth literacy of older adults managing Type 2 diabetes through a blended educational training program. This program consists of five modules delivered over ten weeks, with sessions held every other week, each lasting approximately 90 minutes. Prior to the training, a pre-study will be conducted to tailor the content based on feedback from focus groups that reflect the target population's characteristics. The primary goal is to improve participants' eHealth literacy, measured using the eHEALS scale after the training period.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Low eHealth literacy (eHeals scale ≤ 29)
* No acute or untreated medical problems
* Mini Mental State Examination (MMSE) ≥ 24
* Geriatric Depression Scale (GDS) \< 2

Exclusion Criteria:

* A myocardial infarction or stroke within 6 months
* Painful arthritis, spinal stenosis, amputation, painful foot lesions or neuropathy limiting balance and mobility
* Uncontrolled hypertension
* Advanced Parkinson's disease or other neuromuscular disorder
* Metastatic cancer or immunosuppressive therapy
* Significant visual or hearing impairment

Where it's running

• IRCCS INRCA Hospital
  Ancona, Italy Recruiting
• AOU Ospedaliera Marche
  Ancona, Italy Not yet recruiting

Study contacts

• Principal investigator: Roberta Bevilacqua — IRCCS INRCA, Ancona, Italy
• Study coordinator: Anna Rita Bonfigli
• Email: a.bonfigli@inrca.it
• Phone: 0718003719

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Acute Blood Flow Restriction Walking in Type 2 Diabetes

  This study tests whether adding blood flow restriction to treadmill walking affects immune cells in adults with type 2 diabetes.

  Recruiting University of British Columbia · Kelowna, British Columbia · NCT07928531

• Continuous Glucose Monitoring in Type 2 Diabetes Not on Insulin

  This study tests whether using a continuous glucose monitoring system helps people with type 2 diabetes who aren’t using insulin to improve blood sugar control and quality of life.

  Recruiting Medical University of Bialystok · Bialystok · NCT07919236

• Differentiating heart disease in autoimmune vs. type 2 diabetes

  This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.

  Recruiting University of Roma La Sapienza · Rome, Roma · NCT07911007

• Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses

  This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.

  Recruiting at 2 sites German Institute of Human Nutrition · Berlin and 1 other locations · NCT07888257

• Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar

  This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.

  Recruiting German Institute of Human Nutrition · Potsdam, Potsdam-Rehbrücke · NCT07868601

• Switching to Zenagamtide From Tirzepatide in Adults With Overweight or Obesity With or Without Type 2 Diabetes

  This study tests whether adults who are overweight or have obesity (with or without type 2 diabetes) can switch from tirzepatide to a new treatment called zenagamtide to find a tolerable dose.

  Recruiting at 2 sites Phase 1 Novo Nordisk A/S · Glendale, California and 1 other locations · NCT07868354

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.